A Study Of The Efficacy Of Atorvastatin In Lowering Cholesterol In Latin American Patients With High Cholesterol (LA ATGOAL)

Viatris

Status and phase: Completed; Phase 4

Conditions: Dyslipidemias

Treatments: Drug: Atorvastatin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00645151

A2581104

Details and patient eligibility

About

The purpose of this study is to determine the percentage of patients who would reach a cholesterol goal after atorvastatin treatment.

Enrollment: 512 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with high cholesterol eligible for treatment with baseline LDL-C level of less than or equal to 220 mg/dL
• Willingness to follow diet

Exclusion criteria

• Triglycerides less than or equal to 400 mg/dL
• Hemoglobin A1c >10%

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

512 participants in 3 patient groups

High Risk

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Drug: Atorvastatin

Low Risk

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Drug: Atorvastatin

Medium Risk

Experimental group

Treatment:

Drug: Atorvastatin

Drug: Atorvastatin

Drug: Atorvastatin